Probiotics in Antibiotic-Associated Diarrhea and Clostridium difficile Infection
Hania Szajewska
Abstract
Hania Szajewska
Abstract
Antibiotic-associated diarrhea (AAD) is a common pediatric disorder. This chapter summarizes the available evidence on the efficacy of probiotics in children in the prevention and treatment of any diarrhea associated with the use of antibiotics and that was caused by Clostridium difficile . Results emerging from pediatric trials provide evidence of a moderate beneficial effect of selected probiotic microorganisms, such as Saccharomyces boulardii or Lactobacillus GG, in the prevention of AAD in children.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Antibiotic-associated diarrhea (AAD) is a common pediatric disorder. This chapter summarizes the available evidence on the efficacy of probiotics in children in the prevention and treatment of any diarrhea associated with the use of antibiotics and that was caused by Clostridium difficile . Results emerging from pediatric trials provide evidence of a moderate beneficial effect of selected probiotic microorganisms, such as Saccharomyces boulardii or Lactobacillus GG, in the prevention of AAD in children.
Key concepts: Saccharomyces boulardii, Antibiotic-associated diarrhea, Diarrhea, Clostridium difficile, Probiotic, Antibiotics, Medicine, C difficile